captopril has been researched along with Cardiac Remodeling, Ventricular in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (3.64) | 18.2507 |
2000's | 33 (60.00) | 29.6817 |
2010's | 19 (34.55) | 24.3611 |
2020's | 1 (1.82) | 2.80 |
Authors | Studies |
---|---|
Ahmed, AA; Ahmed, AAE; El Morsy, EM; Mohamed, SK; Nofal, S | 1 |
Cai, W; Qiu, L; Sun, H; Zhang, Q; Zhou, Y; Zhou, Z; Zhu, X | 1 |
Adamcova, M; Aziriova, S; Balazova, L; Celec, P; Krajcirovicova, K; Pechanova, O; Repova, K; Simko, F; Tothova, L; Vrankova, S; Zorad, S | 1 |
Fan, Y; Mann, MJ; Simpson, PC; Xu, Y; Yang, YL; Yeh, CC | 1 |
Berkban, T; Bunbupha, S; Kukongviriyapan, U; Kukongviriyapan, V; Maneesai, P; Pakdeechote, P; Potue, P; Prachaney, P | 1 |
Arsenault, M; Couet, J; Dhahri, W; Drolet, MC; Gascon, S; Grenier, A; Lecomte, R; Rousseau, JA; Roussel, E; Sarrhini, O; Zendaoui, A | 1 |
Chen, Y; Gu, J; Huang, WH; Li, ZY; Ouyang, DS; Tan, ZR; Wang, JJ; Yan, J; Zhou, G; Zhou, HH | 1 |
Mei, X; Wang, J; Zhang, Q; Zhang, X | 1 |
Chai, X; Han, J; Li, C; Qiu, Q; Shi, T; Wang, W; Wang, Y; Wu, Y | 1 |
Ding, Z; Ge, J; Gong, H; Jiang, G; Li, Y; Wang, S; Wang, X; Wu, J; Ye, Y; Yin, P; Yuan, J; Zhang, W; Zhou, J; Zou, Y | 1 |
Chen, C; Gao, J; Gao, Y; Guo, J; Wang, H; Wu, R | 1 |
Adamcova, M; Krajcirovicova, K; Matuskova, J; Paulis, L; Pechanova, O; Pelouch, V; Simko, F | 1 |
Chen, CX; Gao, JP; Gu, WL; Huang, XY | 1 |
Bing, OH; Brooks, WW; Colucci, WS; Conrad, CH; Robinson, KG | 1 |
Blankesteijn, WM; Daemen, MJ; Fujimoto, A; Fujimoto, S; Hofstra, L; Isobe, S; Li, P; Lovhaug, D; Narula, J; Narula, N; Petrov, A; Pitt, B; Reutelingsperger, C; Smits, JF; van den Borne, SW; Vannan, MA; Wong, ND; Zandbergen, HR; Zannad, F | 1 |
Adamcova, M; Bednarova, K; Krajcirovicova, K; Mullerova, M; Paulis, L; Pechanova, O; Pelouch, V; Simko, F | 1 |
Baldo, MP; Dantas, EM; Lunz, W; Mill, JG; Pimentel, EB; Rocha, WA; Rodrigues, SL | 1 |
Chen, BJ; Feng, JX; Gao, YL; Li, ZS; Meng, LQ; Su, XX; Xia, XL | 1 |
Adamcova, M; Bednarova, K; Celec, P; Krajcirovicova, K; Palffy, R; Paulis, L; Pechanova, O; Pelouch, V; Simko, F; Vrankova, S | 1 |
Chen, CX; Huang, XY; Li, YM; Liu, Y; Wu, XM; Zhang, XM | 1 |
Amigoni, M; Califf, R; Køber, L; Levine, RA; McMurray, JJ; Meris, A; Pfeffer, MA; Solomon, SD; Thune, JJ; Velazquez, E; Verma, A | 1 |
Fukamizu, A; Hashimoto, M; Ishida, J; Ishimaru, T; Kunita, S; Matsukura, T; Nakamura, A; Nakamura, S; Sugiyama, F; Yagami, K | 1 |
da Costa Rebelo, RM; Schlüter, KD; Schreckenberg, R | 1 |
Chida, M; Fujii, R; Fukuchi, M; Ido, T; Imahori, Y; Kagaya, Y; Namiuchi, S; Otani, H; Shirato, K; Takeda, M; Tezuka, F; Watanabe, J; Yamane, Y | 1 |
Braunwald, E; Goldman, S; Lee, D; Pfeffer, MA; Plappert, T; Rouleau, JL; St John Sutton, M | 1 |
Bach, LA; Burrell, LM; Dean, RG | 1 |
Baggi, JM; Brandi, JM; Cordeiro, JA; de Godoy, MF; Joaquim, MR; Maia, LN; Nicolau, JC; Santos, M; Vítola, JV | 1 |
Clarke, K; Cole, MA; Hulbert, K; Lygate, CA; Monfared, M; Neubauer, S | 1 |
Arsenault, M; Couet, J; Drolet, MC; Gaudreau, M; Gauthier, C; Lachance, D; Lapointe, E; Plante, E; Roussel, E | 1 |
Geltman, EM; Kenchaiah, S; Lamas, GA; Parker, JO; Pfeffer, MA; Plappert, T; Rouleau, JL; Sasson, Z; Solomon, SD; St John Sutton, M | 1 |
Berecek, KH; Raizada, M; Reaves, P | 1 |
Babal, P; Luptak, I; Matuskova, J; Pechanova, O; Pelouch, V; Simko, F; Torok, J | 1 |
Balding, LC; Burns, WC; Burrell, LM; Candido, R; Cao, Z; Dean, RG; Twigg, SM | 1 |
Baltogiannis, GG; Hatzistergos, KE; Kolettis, TM; Kyriakides, ZS; Malamou-Mitsi, V; Mitsi, AC; Niokou, D; Papalois, A; Pappa, L; Tsalikakis, DG | 1 |
Dilsizian, V; Eckelman, WC; Narula, J; Narula, N; Shirani, J | 1 |
Brower, GL; Janicki, JS; Levick, SP | 1 |
Anand, I; Dickstein, K; Manhenke, C; Ng, L; Orn, S; Squire, IB | 1 |
Dai, EQ; Di, Y; He, W; Liu, ZQ; Tong, CQ; Wang, YH | 1 |
Backer, CL; Crawford, SE; Gonzalez-Crussi, F; Hsueh, W; Huang, L; Liu, H; Mavroudis, C; Mu, Y; Takami, H | 1 |
Agelopoulos, G; Alexopoulos, D; Chiladakis, JA; Karapanos, G; Manolis, AS | 1 |
Chida, M; Fukuchi, M; Ido, T; Kagaya, Y; Namiuchi, S; Shirato, K; Takahashi, C; Tezuka, F; Watanabe, J; Yamane, Y | 1 |
Bernátová, I; Pechánová, O; Pelouch, V; Simko, F | 1 |
Bittner, V; Ford, T; Goldman, S; Gradman, A; Kinan, D; Konstam, MA; La Bresh, K; Lewis, W; Patten, RD; Ramahi, T; Rand, W; Segal, R; Self, KS; Smith, JJ; Thomas, I; Udelson, JE | 1 |
Armstrong, PW | 1 |
Altmann, C; Konermann, M; Laschewski, F; Odenthal, HJ; Rawert, B; Sanner, BM; Trappe, HJ | 1 |
Chung, ES; Lancaster, EJ; Mela, T; Meyer, TE; Norton, GR; Sprott, S; Tsotetsi, OJ; Woodiwiss, AJ | 1 |
Altmann, C; Konermann, M; Laschewski, F; Rawert, B; Sanner, BM; Trappe, HJ | 1 |
Mazur, NA; Vikent'ev, VV | 1 |
Goto, K; Kagaya, Y; Kondo, H; Ohta, J; Shirato, K; Sugie, T; Takahashi, J; Takeda, M; Watanabe, J | 1 |
Khattar, RS; Lahiri, A; Senior, R; Soman, P; van der Does, R | 1 |
Bottero, G; Ceci, V; Coletta, C; Pajes, G; Pasquale, M; Putini, RL; Ricci, R; Salustri, A | 1 |
Casis, O; Echevarria, E; Espiña, L; Gallego, M; Iriarte, MM; Vegas, L | 1 |
Chen, H; Pan, W; Pu, S; Shen, X; Yang, Y; Zhang, G | 1 |
Adam, A; Blais, C; Clément, R; Gosselin, H; Lapointe, N; Parker, T; Rouleau, JL; Sirois, MG | 1 |
Kyselovic, J; Pelouch, V; Simko, F | 1 |
1 review(s) available for captopril and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Early imaging in heart failure: exploring novel molecular targets.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Fluorine Radioisotopes; Heart Failure; Humans; Imidazoles; Lisinopril; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Renin-Angiotensin System; Ventricular Remodeling | 2007 |
11 trial(s) available for captopril and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction.
Topics: Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Echocardiography, Doppler, Color; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Monitoring, Physiologic; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prospective Studies; Reference Values; Reproducibility of Results; Risk Assessment; ROC Curve; Severity of Illness Index; Sex Factors; Statistics, Nonparametric; Stroke Volume; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left; Ventricular Remodeling | 2012 |
Left ventricular remodeling and ventricular arrhythmias after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Cardiomegaly; Demography; Double-Blind Method; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Premature Complexes; Ventricular Remodeling | 2003 |
Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Radionuclide Ventriculography; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling | 2003 |
Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Heart Ventricles; Humans; Losartan; Magnetic Resonance Imaging; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Severity of Illness Index; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2007 |
Effects of early captopril therapy after myocardial infarction on the incidence of late potentials.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Captopril; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors; Ventricular Dysfunction, Left; Ventricular Remodeling | 2000 |
Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Cardiac Volume; Double-Blind Method; Female; Heart Failure; Humans; Losartan; Male; Myocardial Contraction; Radionuclide Ventriculography; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stroke Volume; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2000 |
[Effect of ACE-inhibitors on left ventricular remodeling after acute anterior or posterior myocardial infarct. Cine- magnetic resonance tomography study].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fosinopril; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Infarction; Stroke Volume; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2000 |
Is the tissue affinity of ACE inhibitors of relevance for the remodeling of the left ventricular wall following myocardial infarction? Estimations with cine magnetic resonance imaging.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fosinopril; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left; Ventricular Remodeling | 2000 |
[Postinfarction remodeling of the left atrium and left ventricle: effects of long-term treatment with beta adrenergic blockers and angiotensin converting enzyme inhibitors].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Atrial Function, Left; Captopril; Data Interpretation, Statistical; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors; Ventricular Remodeling | 2001 |
Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Cardiac Catheterization; Carvedilol; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Stroke Volume; Treatment Outcome; Ventricular Remodeling | 2001 |
Effect of early treatment with captopril and metoprolol singly and together on postinfarction left ventricular remodeling.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Echocardiography; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Prospective Studies; Treatment Outcome; Ventricular Remodeling | 2001 |
43 other study(ies) available for captopril and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Targeting the adenosine monophosphate-activated protein kinase signalling pathway by bempedoic acid attenuates Angiotensin II-induced cardiac remodelling in renovascular hypertension in rats.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Captopril; Hypertension; Hypertension, Renovascular; Male; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Ventricular Remodeling | 2023 |
Vaccarin administration ameliorates hypertension and cardiovascular remodeling in renovascular hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Captopril; Disease Models, Animal; Flavonoids; Gene Expression Regulation; Glycosides; Hypertension; Male; Norepinephrine; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Renin; Ventricular Remodeling | 2018 |
Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril.
Topics: Acetylcysteine; Animals; Antihypertensive Agents; Captopril; Disease Models, Animal; Fibrosis; Heart Ventricles; Hypertension; Light; Male; Melatonin; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Ventricular Remodeling | 2017 |
Shift toward greater pathologic post-myocardial infarction remodeling with loss of the adaptive hypertrophic signaling of alpha1 adrenergic receptors in mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Male; MAP Kinase Signaling System; Mice; Mice, Knockout; Myocardial Infarction; Receptors, Adrenergic, alpha-1; Ventricular Remodeling | 2017 |
Hesperidin Prevents Nitric Oxide Deficiency-Induced Cardiovascular Remodeling in Rats via Suppressing TGF-β1 and MMPs Protein Expression.
Topics: Animals; Blood Pressure; Captopril; Gene Expression Regulation; Hesperidin; Male; Matrix Metalloproteinases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Vascular Remodeling; Ventricular Remodeling | 2018 |
Angiotensin II-converting enzyme inhibition improves survival, ventricular remodeling, and myocardial energetics in experimental aortic regurgitation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Insufficiency; Captopril; Disease Models, Animal; Echocardiography; Energy Metabolism; Extracellular Matrix; Fatty Acids; G-Protein-Coupled Receptor Kinase 5; Hypertrophy, Left Ventricular; Myocardium; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Rats; Severity of Illness Index; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Hypertensive cardiac remodeling effects of lignan extracts from Eucommia ulmoides Oliv. bark--a famous traditional Chinese medicine.
Topics: Aldehyde Reductase; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Eucommiaceae; Lignans; Male; Plant Bark; Plant Extracts; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rhodanine; Thiazolidines; Ventricular Remodeling | 2013 |
Hydroxysafflor yellow A attenuates left ventricular remodeling after pressure overload-induced cardiac hypertrophy in rats.
Topics: Animals; Apoptosis; Captopril; Cardiomegaly; Carthamus tinctorius; Chalcone; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Hypertension; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medicine, Chinese Traditional; Myocytes, Cardiac; Quinones; Rats; Rats, Wistar; Ventricular Remodeling | 2014 |
Qishenyiqi protects ligation-induced left ventricular remodeling by attenuating inflammation and fibrosis via STAT3 and NF-κB signaling pathway.
Topics: Angiotensin II; Animals; Captopril; Drugs, Chinese Herbal; Fibrosis; Heart Failure; Heart Ventricles; Hemodynamics; Inflammation; Interleukin-6; Ligation; Male; Matrix Metalloproteinases; NADPH Oxidases; NF-kappa B; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor; Ventricular Remodeling | 2014 |
Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload-induced Cardiac Hypertrophy and Remodeling in Male Mice.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Autophagy; Blood Pressure; Captopril; Chronic Disease; Disease Models, Animal; Drug Therapy, Combination; Drugs, Chinese Herbal; Gene Expression Regulation; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Male; Metoprolol; Mice, Inbred C57BL; Myocytes, Cardiac; Signal Transduction; Tetrazoles; Ventricular Function, Left; Ventricular Remodeling | 2015 |
Cardioprotective effect of polydatin on ventricular remodeling after myocardial infarction in coronary artery ligation rats.
Topics: Aldosterone; Animals; Antioxidants; Captopril; Collagen; Coronary Occlusion; Coronary Vessels; Endothelin-1; Glucosides; Heart Ventricles; Hydroxyproline; Hypertrophy; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Nitric Oxide; Phytotherapy; Plant Extracts; Polygonum; Rats, Sprague-Dawley; Renin-Angiotensin System; Stilbenes; Ventricular Remodeling | 2015 |
Effects of captopril, spironolactone, and simvastatin on the cardiovascular system of non-diseased Wistar rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Wistar; Simvastatin; Spironolactone; Ventricular Remodeling | 2015 |
The effect of angoroside C on pressure overload-induced ventricular remodeling in rats.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Captopril; Collagen; Constriction, Pathologic; Coumaric Acids; Disease Models, Animal; Endothelin-1; Heart; Heart Rate; Hydroxyproline; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Scrophularia; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1; Trisaccharides; Ventricular Remodeling | 2015 |
L-arginine fails to prevent ventricular remodeling and heart failure in the spontaneously hypertensive rat.
Topics: Animals; Arginine; Captopril; Cardiomegaly; Heart; Heart Failure; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ventricular Remodeling | 2009 |
Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carbocyanines; Cardiovascular Agents; Disease Models, Animal; Drug Therapy, Combination; Echocardiography; Fibrillar Collagens; Fibroblasts; Fibrosis; Losartan; Mice; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Oligopeptides; Predictive Value of Tests; Spironolactone; Technetium; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Captopril; Hypertrophy, Left Ventricular; Kidney; Male; Melatonin; Mineralocorticoid Receptor Antagonists; NF-kappa B; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Simvastatin; Spironolactone; Ventricular Remodeling | 2009 |
Kinetics of cardiac and vascular remodeling by spontaneously hypertensive rats after discontinuation of long-term captopril treatment.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Captopril; Hypertension; Rats; Rats, Inbred SHR; Rats, Wistar; Substance Withdrawal Syndrome; Time Factors; Vascular Resistance; Ventricular Remodeling | 2010 |
Effects of Tongguan Capsule on post-myocardial infarction ventricular remodeling and cardiac function in rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Capsules; Captopril; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Echocardiography, Doppler; Heart; Male; Myocardial Infarction; Random Allocation; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling | 2010 |
Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Light; Male; Melatonin; NG-Nitroarginine Methyl Ester; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Wistar; Ventricular Remodeling | 2010 |
Effects of ethanolic extract from Radix Scrophulariae on ventricular remodeling in rats.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Chemical Analysis; Captopril; Cardiomegaly; Collagen; Coronary Vessels; Endothelin-1; Ethanol; Gene Expression Regulation; Hemodynamics; Hydroxyproline; Male; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Organ Size; Plant Extracts; Plant Roots; Random Allocation; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger; Scrophularia; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2012 |
Short-term suppression of the renin-angiotensin system in mice associated with hypertension during pregnancy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Female; Fetal Growth Retardation; Hypertension, Pregnancy-Induced; Imidazoles; Male; Mice; Mice, Inbred C57BL; Olmesartan Medoxomil; Placenta; Pregnancy; Renin-Angiotensin System; Tetrazoles; Time Factors; Ventricular Remodeling | 2012 |
Adverse cardiac remodelling in spontaneously hypertensive rats: acceleration by high aerobic exercise intensity.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Female; Hypertension; Physical Conditioning, Animal; Rats; Rats, Inbred SHR; Rats, Wistar; Risk Factors; Ventricular Remodeling | 2012 |
Effect of angiotensin converting enzyme inhibition on myocardial phosphoinositide metabolism visualised with 1-[1-11C]-butyryl-2-palmitoyl-rac-glycerol in myocardial infarction in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Autoradiography; Captopril; Carbon Radioisotopes; Glycerides; Heart Ventricles; Humans; Male; Myocardial Infarction; Myocardium; Phosphatidylinositols; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Reference Values; Tissue Distribution; Ventricular Remodeling | 2002 |
Upregulation of cardiac insulin-like growth factor-I receptor by ACE inhibition after myocardial infarction: potential role in remodeling.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Female; Immunohistochemistry; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Receptor, IGF Type 1; RNA, Messenger; Up-Regulation; Ventricular Remodeling | 2003 |
The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiotonic Agents; Drug Therapy, Combination; Echocardiography; Heart Failure; Male; Myocardial Infarction; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Treatment Failure; Ventricular Remodeling | 2003 |
Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Insufficiency; Captopril; Cardiac Output; Cardiomyopathy, Dilated; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Fibronectins; Gene Expression; Hypertrophy, Left Ventricular; Male; Rats; Rats, Wistar; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2004 |
Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial).
Topics: Antihypertensive Agents; Blood Pressure; Captopril; Echocardiography; Female; Heart Ventricles; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left; Ventricular Remodeling | 2004 |
Effects of early perturbation of the renin-angiotensin system on cardiovascular remodeling in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Captopril; Coronary Vessels; Hypertension; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Ventricular Remodeling | 2005 |
Protein remodeling of the heart ventricles in hereditary hypertriglyceridemic rat: effect of ACE-inhibition.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Captopril; Heart Ventricles; Hypertriglyceridemia; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Organ Size; Proteins; Rats; Rats, Wistar; Vasodilator Agents; Ventricular Remodeling | 2005 |
Connective tissue growth factor and cardiac fibrosis after myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Collagen Type I; Connective Tissue Growth Factor; Fibrosis; Immediate-Early Proteins; Immunohistochemistry; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Rats; RNA, Messenger; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling | 2005 |
Early, intracoronary growth hormone administration attenuates ventricular remodeling in a porcine model of myocardial infarction.
Topics: Animals; Antihypertensive Agents; Captopril; Disease Models, Animal; Growth Hormone; Humans; Myocardial Infarction; Neovascularization, Pathologic; Swine; Ventricular Remodeling | 2006 |
Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteriovenous Shunt, Surgical; Captopril; Compliance; Disease Models, Animal; Heart Failure; Hypertrophy, Left Ventricular; Lisinopril; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Myocardial Contraction; Myocardium; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Time Factors; Venae Cavae; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2007 |
Effect of yiqi huoxue recipe on cardiac function and ultrastructure in regression of pressure overload-induced myocardial hypertrophy in rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cardiomegaly; Disease Models, Animal; Drugs, Chinese Herbal; Heart; Male; Myocardium; Phytotherapy; Pressure; Rats; Rats, Wistar; Remission Induction; Ventricular Remodeling | 2007 |
Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Azepines; Captopril; Coronary Disease; Disease Models, Animal; Drug Therapy, Combination; Heart Transplantation; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Random Allocation; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous; Treatment Outcome; Triazoles; Ventricular Remodeling | 1999 |
Regional and temporal profiles of phorbol 12,13-dibutyrate binding after myocardial infarction in rats: effects of captopril treatment.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Autoradiography; Captopril; Carcinogens; Male; Myocardial Infarction; Organ Size; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Wistar; Signal Transduction; Time Factors; Ventricular Remodeling | 2000 |
Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Captopril; Collagen; DNA; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; Muscle Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Rats; Rats, Wistar; Remission, Spontaneous; Renin-Angiotensin System; RNA; Ventricular Remodeling | 2000 |
Left ventricular dysfunction: causes, natural history, and hopes for reversal.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Female; Heart; Heart Failure; Humans; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Randomized Controlled Trials as Topic; Spironolactone; Ventricular Dysfunction, Left; Ventricular Remodeling | 2000 |
Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Body Weight; Captopril; Collagen; Constriction, Pathologic; Disease Models, Animal; Echocardiography; Hydroxyproline; Hypertrophy, Left Ventricular; In Vitro Techniques; Isoproterenol; Male; Myocardium; Organ Size; Perfusion; Rats; Rats, Sprague-Dawley; Regression Analysis; Systole; Ventricular Dysfunction, Left; Ventricular Remodeling | 2001 |
Gene expression and in situ localization of diacylglycerol kinase isozymes in normal and infarcted rat hearts: effects of captopril treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Body Weight; Captopril; Diacylglycerol Kinase; Disease Models, Animal; Gene Expression; Granulocytes; Heart Ventricles; Immunohistochemistry; In Situ Hybridization; Isoenzymes; Macrophages; Male; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; RNA, Messenger; Ventricular Remodeling | 2001 |
Spironolactone and captopril attenuates isoproterenol-induced cardiac remodelling in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiomegaly; Collagen; Dose-Response Relationship, Drug; Endomyocardial Fibrosis; Heart Ventricles; Isoproterenol; Myocardium; Organ Size; Rats; Rats, Sprague-Dawley; Spironolactone; Ventricular Remodeling | 2001 |
Comparative effects of losartan and captopril on ventricular remodeling and function after myocardial infarction in the rat.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Heart Function Tests; Losartan; Male; Myocardial Infarction; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Ultrasonography; Ventricular Remodeling | 1998 |
Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Hemodynamics; Male; Myocardial Infarction; Myocardium; Neurotransmitter Agents; Protease Inhibitors; Pyridines; Rats; Rats, Wistar; Thiazepines; Treatment Outcome; Ventricular Remodeling | 2002 |
Captopril fails to reverse hypertrophy of the left ventricle induced by aortic insufficiency in rabbits.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aortic Valve Insufficiency; Blood Pressure; Captopril; Chinchilla; Hydroxyproline; Hypertrophy, Left Ventricular; Male; Organ Size; Rabbits; Ventricular Remodeling | 2002 |